Regenerative Medicine is an interdisciplinary field that uses engineering and life science principles to stimulate regeneration in damaged or wounded organs and tissues. This is a new direction on the healthcare market. The first medical product was approved in 2004: Macugen (VEGF165 gene therapy; Pfizer) for treatment of age-related macular degeneration (vision loss). The discovery of medicines that can regenerate tissues and reduce dependency on transplants is motivated by increasing organ and tissue dysfunction due to population aging. In the year 2021, the Regenerative Medicine market size reached the $ 9 billion mark.